Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors
Clinical trial NCT06231277 · COMPLETED
Trial details
- NCT number
- NCT06231277
- Sponsor
- Zhuhai Beihai Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2023-03-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.